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Abstract 
 
Because malignant lymphoma, the second most common malignant tumor of the head 
and neck, and squamous cell carcinoma (SCC), the most common malignant tumor of 
the head and neck, require different treatments, it is important to be able to 
differentiate them.  In the present study, we attempted to differentiate malignant 
lymphomas from SCCs using dynamic contrast-enhanced MRI (DCE-MRI).  Seventeen 
lesions (in 8 cases) of malignant lymphoma and 30 cases of SCC were compared by 
DCE-MRI. 
Thirteen of 17 malignant lymphomas (76.5 %) showed the maximum contrast index 
(CI) at 90-180 s, while 26 of 30 SCCs (86.7%) showed the maximum CI at a much faster 
60-105 s.  There was a statistically significant difference between SCC and malignant 
lymphoma in the time needed reach the maximum CI (p=0.0177).  There was also 
significant difference between SCC and malignant lymphoma in their maximum CIs 
(p<0.001), with the maximum CIs of 29/30 SCCs  (96.7%) above 2.0, while 12/17 
malignant lymphomas (70.6%) showed CIs of less than 2.0.  We consider these findings 
to be useful for distinguishing lymphomas from SCCs. 
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1. Introduction 
 
Malignant lymphoma is the second most common malignant tumor of the head and 
neck, and is treated by chemotherapy, radiotherapy, or a combination of these.  For 
squamous cell carcinoma (SCC), the most common malignant tumor of the head and 
neck, surgery is usually the performed treatment.  Because malignant lymphomas and 
SCCs require different treatments, it is important to be able to differentiate them.  
MRI is effective for diagnosing tumors and has some advantages over traditional 
techniques, especially in detecting soft tissue lesions [1, 2].  However, MRI 
examination has not yet come into use for the differential diagnosis of tumors.  
Therefore, plain MR signals often cannot contribute to a differential diagnosis or to be 
used to determine whether a tumor is benign or malignant.  It has been reported that 
dynamic contrast-enhanced MRI (DCE-MRI) is useful for the differential diagnosis of 
some tumors, and many investigators have attempted to use it to identify differences 
between benign and malignant tumors, as well as to assess the malignancy of tumors 
[3-6].  We have also reported the usefulness of DCE-MRI for tumor diagnosis [7-9].  
Nevertheless, there have been few reports to date of DCE-MRI used in malignant 
lymphoma and/or SCC of the head and neck for diagnostic or predictive purposes. 
In the present study, we attempted to differentiate malignant lymphomas from SCCs in 
the head and neck using DCE-MRI. 
 
2. Materials and methods 
 
2.1.  Materials 
 
Thirty patients with primary head and neck SCC (Table 1) and 8 patients (17 lesions) 
with malignant lymphoma (Table 2) underwent DCE-MRI at our hospital, the SCC 
patients between 1997 and 1999, and the lymphoma patients between 1999 and 2002.  
All subjects gave their informed consent.  The SCC patient population consisted of 14 
females and 16 males regarding in age from 47 to 93 years old (mean, 69.3 years old).  
The lymphoma patients were 1 female and 7 males who were between 50 and 82 years 
old (mean, 63.6 years old).  There was no significant difference between SCC and 
malignant lymphoma patients in age distribution (p=0.1876).   The primary site 
distribution of SCC was as follows: tongue, 9; upper gingival, 6; lower gingival, 6; floor 
of mouth, 4; cheek, 3; from cheek to lower gingival, 1; and from tongue to pharynx, 1.  
The distribution of the 17 lymphoma lesions was as follows: submandibular region, 8; 
palate, 1; tonsil, 1; buccal, 3; orbit, 2; submental, 2 (Tables 1 and 2). 
 
2.2. MR sequence 
 
The MR examination was performed on a 1.5 T unit (Magnetom Vision; Siemens, 
Erlangen, Federal Republic of Germany) with a CP head coil or a head-neck coil.  
Routine T1- and T2-weighted images were acquired with spin-echo and turbo spin-echo 
sequences with frequency-selective fat-suppression in the transverse and the coronal 
planes, respectively.  For DCE-MRI, 21 consecutive data sets were acquired for 315 sec 
(14 sec/1 scan) with three-dimensional fast imaging with steady state precession 
(repetition time / echo time /flip angle=5/2/25 degree, 16 slices for 48 mm of a slab 
thickness, resulting in 3 mm of effective slice thickness) and frequency-selective 
fat-suppressed T1-weighted images were immediately acquired as contrast-enhanced 
T1-weighted images.  Intravenous injection of Gd-DTPA (Magnevist; Nihon Schering, 
Osaka, Japan) was archived manually at a rate of approximately 2 ml / sec through a 
21-gauge butterfly needle inserted into a vein in the cubital fossa.  The injection of a 
contrast medium started 6 sec before the initiation of a second scan of 21 DCE-MRI data 
sets.  The DCE-MR images were acquired repeatedly at 600, 615, 900, and 915 sec 
after the start of the injection of contrast medium. 
 
2.3.  Data analysis 
 
A region of interest (ROI) was drawn to include the whole mass area selected from 
post-contrast images.  The mean signal intensity (SI) of the ROIs was then measured 
on the monitor using the electric cursor.  Contrast index (CI) versus time curves 
(CI-curves) were drawn.  CI was calculated by the following formula: CI=(SIt-SI0)/SI0, 
where SIt is the mean signal intensity at the time t after the injection of contrast 
medium, and SI0 is the mean signal intensity before the injection of contrast medium. 
 
2.4.  Statistical analysis. 
 
Statistical analysis of the relationship between the maximum CI of SCC and that of 
lymphoma was carried out using StatView software (for Macintosh, Version 5.0, SAS 
Institute Inc., San Francisco, CA, USA).  Statistical significance was assessed by the 
Students t-test and p values of <0.05 were considered to be significant. 
 
3.  Results 
 
The CI curves of malignant lymphoma and SCC, calculated from a dynamic series, are 
shown in Figures 1 and 2, respectively.  Of 17 curves of malignant lymphoma, 14 
(82.4%) increased rapidly, followed by a relatively rapid initial decrease and a gradual 
decrease thereafter.  The remaining 3 cases (17.6%) had no apparent peak, reaching a 
maximum CI and sustaining a temporary plateau, followed by a gradual decrease 
thereafter.   Thirteen curves of malignant lymphoma (76.5%) reached their maximum 
CI at 90-180 s and the remaining 4 curves (13.5%) reached maximum CI at 45-60 s.  
Although the maximum CIs of 5 the malignant lymphomas lesions (29.4%) were beyond 
2.0, 12 curves (70.6%) showed CIs of less than 2.0.  The appearance of multiple lesions 
is one of the characteristic findings of malignant lymphoma, and the CI curves of the 
multiple lesions of individual patients showed similar patterns. 
All CI curves of SCCs showed a pattern of rapid increase followed by rapid initial 
decrease and gradual decrease thereafter.  The time needed to reach the maximum CI 
of 26/30 SCCs (86.7%) was 60-105 s and tended to be rapid compared with that of 
malignant lymphomas.  The maximum CIs of 29/30 SCCs (96.7%) were above 2.0. 
The relationship between the maximum CI and the time needed to reach the maximum 
CI is plotted in Figure 3.  Of 17 malignant lymphoma lesions in 8 patients, 3 lesions (in 
2 patients) could not be differentiated from SCC lesions, but the remaining 14 lesions 
(82.4%) were successfully differentiated from SCC lesions on the basis of the line drawn 
in the Figure 3.  Furthermore, the mean maximum CI of SCC was 2.88±0.60 (range, 
1.82-4.11), while the mean maximum CI of malignant lymphoma was 1.96±0.86 (range, 
0.98-4.24), a statistically significant difference (p<0.001) (Tables 1 and 2).  We also 
found a significant difference (p=0.0177) in the mean times for reaching maximum CI, 
which were 97.1±38.3 and 78.5±29.1 in SCC and malignant lymphoma patients, 
respectively. 
 
4.  Discussion 
 
Dynamic features show the characteristic features of tumors and may be useful for 
making a differential diagnosis.  DCE-MRI may therefore be useful in diagnosing some 
tumors and in predicting their biological behavior.  However, there have been few 
reports to date of DCE-MRI used diagnostic or predictive purposes in cases of tumors of 
head and neck.  Although there have been a few reports on the basis of DCE-MRI in 
malignant lymphoma and SCC patients, [10, 11], there has been no report to date on the 
use of DCE-MRI for the purpose of distinguishing between these lesions.  In the 
present study, we examined the usefulness of DCE-MRI for differentiating lymphomas 
from SCCs using the CI curve.  The CI curves 76.5% of malignant lymphoma showed a 
maximum CI at 90-180 s, while those of 86.7% of SCCs were more rapid at a maximum 
Cis of 60-105 s.  There is a thus significant difference between malignant lymphoma 
and SCC in the time needed to reach the maximum CI (p=0.0177).  Furthermore, the 
maximum CIs of 28/29 SCCs (96.6%) were above 2.0, while 12/17 lymphomas (70.6%) 
showed CIs of less than 2.0; the maximum CIs was thus significantly larger in SCCs 
compared with malignant lymphomas (p<0.001).  In malignant lymphoma, there were 
3/17 lesions (17.6 %) whose time to reach the maximum CI was within 105 s and whose 
maximum CI was above 2.0.  In SCCs, there were no lesions in which the time to reach 
the maximum CI was more than 90 s and whose maximum CI was less than 2.0.  Thus, 
DCE-MRI might useful for distinguishing malignant lymphomas from SCCs.  In the 
present study, when the relationship between the maximum CI and the time needed to 
reach the maximum CI was plotted, 14 of 17 malignant lymphoma lesions (82.4%) were 
clearly distinct from SCC lesions.   We therefore believe that DCE-MRI might be 
useful for distinguishing malignant lymphomas from SCCs. 
 
Acknowledgement 
 
This work was supported by a Grant-in-Aid for Scientific Research on Priority Areas of 
Okayama University and Grant-in-Aid (14370603, 14771037, 14771038) for Scientific 
Research from the Ministry of Education, Science, Sports and Culture of Japan. 
References 
 
[1]  Sipro RH:  Management of malignant tumors of the salivary glands.  Oncology 
1998; 12:671-80. 
[2]  Joe VQ, Weatesson P-L: Tumors of the parotid gland: MR imaging characteristics 
of various histologic types.  AJR 1994;163:433-8. 
[3]  Ikarashi F, Nakano Y, Nonomura N, Kawana M: Radiological findings of 
adenolymphoma (Warthin's tumor). Auris Nasus Larynx 1997;24:405-9. 
[4]  Park J, Inoue S, Ishizuka Y, et al: Salivary gland masses: dynamic MR imaging 
and pathologic correlation. Nippon Igaku Hoshasen Gakkai Zasshi 1997;57:581-5 
(Japanese). 
[5]  Tsushima Y, Matsumoto M, Endo K: Parotid and parapharyngeal tumours: tissue 
characterization with dynamic magnetic resonance imaging. Br J Radiol 1994;67:342-5.. 
[6]  Takashima S, Noguchi Y, Okumura T, Aruga H, Kobayashi T: Dynamic MR 
imaging in the head and neck. Radiology 1993;189:813-21 
[7]  Asaumi J, Matsuzaki H, Hisatomi M, Konouchi H, Shigehara H, Kishi K: 
Application of dynamic MRI to differentiating odontogenic myxomas from 
ameloblastomas.  Eur J Radiol 2002 ;43:37-41. 
[8]  Hisatomi M, Asaumi J, Konouchi H, Yanagi Y, Matsuzaki H, Kishi K:  Assessment 
of ynamic MRI of Warthin's tumors arising as multiple lesions in the parotid glands.  
Oral Oncol 2002;38:369-72. 
[9]  Asaumi J, Shigehara H, Konouchi H, Yanagi Y, Hisatomi M, Matsuzaki H, Kishi K: 
Assessment of carcinoma in the sublingual region based on magnetic resonance imaging. 
Oncol Rep 2002;9:1283-7. 
[10]  Konouchi H, Asaumi J, Yanagi Y, Shigehara H, Hisatomi M, Matsuzaki H, Kishi 
K: Evaluation of tumor proliferation using dynamic contrast enhanced-MRI of oral 
cavity and oropharyngeal squamous cell carcinoma.  Oral Oncol 2003;39:290-285. 
[11]  Suenaga S, Indo H, Noikura T.  Diagnostic value of dynamic magnetic resonance 
imaging for salivary gland diseases: a preliminary study. Dentomaxillofac Radiol. 
2001;30:314-8. 
 
Figure legends 
 
Figure 1 
CI curves of malignant lymphomas 
Thirteen curves of malignant lymphoma (76.5%) reached their maximum CI at 90 ~ 180 
s, and the remaining 4 curves (13.5%) reached maximum CIs at 45-60 s.   Although the 
maximum CIs of 5 malignant lymphoma lesions (29.4 %) were above 2.0, 12 curves 
(70.6%) showed CIs of less than 2.0. 
 
Figure 2 
CI curves of SCCs 
The time needed to reach maximum CI of the CI curves of 26/30 cases (86.7%) was at 
60-105 s and tended to be rapid compared with that of lymphomas.  The maximum CIs 
of 29/30 SCCs (96.7%) were above 2.0. 
 
Figure 3 
Relationship between the maximum CI and the time needed to reach the maximum CI 
The relationship between maximum CI and time needed to reach the maximum CI is 
plotted.  Of 17 malignant lymphoma lesions in 8 patients, 3 lesions (in 2 patients) could 
not be differentiated SCC lesions, but the remaining 14 lesions (82.4%) were 
successfully differentiated SCC lesions on the basis of the line drown in the Figure. 
SCC: closed square, malignant lymphoma: open circle 
Figure 1 
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Table 1  Patient characteristics, maximum CI, time needed to reach the maximum CI in the malignant lymphoma patients 
No. Age (yr) Sex Region Maximum CI Time for reaching 
to Maximun CI(s)
THistopathological diagnosis 
1(case1) 82 M Submandibular 1.87 105 B-cell diffuse large cell type 
2(case2) 55 M Submandibular 3.35 60 B-cell diffuse large cell type 
3(case2) 55 M Submandibular 3.07 45 B-cell diffuse large cell type 
4(case3) 67 M Palate 4.24 90 B-cell diffuse large cell type 
5(case4) 50 F Tonsil 0.98 45 Follicular type 
6(case4) 50 F Submandibular 1.21 45 Follicular type 
7(case5) 71 M Buccal 1.97 105 Be-cell low-grade MALT lymphoma 
8(case5) 71 M Buccal 1.93 135 Be-cell low-grade MALT lymphoma 
9(case5) 71 M Orbit 2.33 165 Be-cell low-grade MALT lymphoma 
10(case5) 71 M Orbit 1.97 120 Be-cell low-grade MALT lymphoma 
11(case6) 58 M Buccal 1.37 180 B-cell diffuse large cell type 
12(case7) 76 M Submandibular 1.43 90 B-cell diffuse large cell type 
13(case7) 76 M Submandibular 1.42 90 B-cell diffuse large cell type 
14(case7) 76 M Submandibular 1.37 90 B-cell diffuse large cell type 
15(case7) 76 M Submandibular 1.54 90 B-cell diffuse large cell type 
16(case7) 76 M Submental 1.49 90 B-cell diffuse large cell type 
17(case8) 50 M Submental 1.83 105 Hodgkin Lymphoma 
mean±SD 66.5±11.0     1.96±0.86  97.1±38.3   
Table 2 Patient characteristics, maximum CI, time needed to reach the maximum CI in the SCC patients 
 
No. Age (yr) Sex Region Maximum CI Time for 
reaching 
Maximum CI (s)
1 77 F Cheek 4.11 60 
2 64 F Lower gingiva 3.86 60 
3 91 M Cheek 3.84 60 
4 66 M Lower gingiva 3.78 90 
5 80 F Floor of mouth 3.58 120 
6 93 M Lower gingiva 3.32 45 
7 85 M Tongue 3.27 45 
8 72 F Floor of mouth 3.18 60 
9 66 M Tongue-Pharynx 3.18 120 
10 55 M Upper gingiva 3.17 60 
11 70 M Cheek 3.09 150 
12 71 M Tongue 3.09 75 
13 68 F Upper gingiva 3.06 45 
14 74 F Upper gingiva 3.05 90 
15 68 M Floor of mouth 3.02 45 
16 61 F Lower gingiva 2.94 75 
17 70 F Tongue 2.8 45 
18 57 M Floor of mouth 2.75 75 
19 49 F Tongue 2.69 135 
20 47 M Cheek-Lower 
gingiva 
2.56 45 
21 83 F Lower gingiva 2.53 120 
22 58 F Tongue 2.33 105 
23 58 M Upper gingiva 2.32 75 
24 87 M Lower gingiva 2.27 75 
25 64 F Tongue 2.26 90 
26 82 F Upper gingiva 2.21 60 
27 57 M Tongue 2.21 105 
28 61 F Tongue 2.17 75 
29 75 M Upper gingiva 2.07 90 
30 70 M Tongue 1.82 60 
mean±SD 69.3±11.9     2.88±0.60  78.5±29.1 
